Annandale Capital, LLC

Position in IQV — Iqvia Holdings Inc.

CIK 1811739 DALLAS, TX

Position in IQV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,024,066

New position

Shares Held

5,300

first reported quarter

Ownership

0.003%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#515

of 1,082 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Annandale Capital, LLC holds $6,095,710 across 4 Diagnostics & Research names. IQV ranks #3 (16.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	5,452	$2,733,414
2	DHR	Danaher Corp /De/	7,827	$1,490,886
3	IQV	Iqvia Holdings Inc. This page	5,300	$1,024,066
4	MEDP	Medpace Holdings, Inc.	1,600	$847,344

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,024,066	5,300	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.